These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26246290)

  • 21. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical services in hospices.
    Berry JI; Pulliam CC; Caiola SM; Eckel FM
    Am J Hosp Pharm; 1981 Jul; 38(7):1010-4. PubMed ID: 7258198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic effects of pharmacists on health outcomes in the United States: A systematic review.
    Chisholm-Burns MA; Graff Zivin JS; Lee JK; Spivey CA; Slack M; Herrier RN; Hall-Lipsy E; Abraham I; Palmer J
    Am J Health Syst Pharm; 2010 Oct; 67(19):1624-34. PubMed ID: 20852164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacist services: insurance need not be the only answer.
    Winckler SC
    J Am Pharm Assoc (Wash); 2002; 42(6):826. PubMed ID: 12482003
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacist compensation for ambulatory patient care services.
    Bradberry JC; Srnka Q
    Am J Manag Care; 1998 Dec; 4(12):1727-35; quiz 1736-7. PubMed ID: 10339105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Costs of pharmaceutical care: can the profession do anything?
    Hopefl AW
    Ann Pharmacother; 1992 Dec; 26(12):1585-8. PubMed ID: 1482817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes.
    Beney J; Bero LA; Bond C
    Cochrane Database Syst Rev; 2000; (3):CD000336. PubMed ID: 10908471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative analysis of remuneration models for pharmaceutical professional services.
    Bernsten C; Andersson K; Gariepy Y; Simoens S
    Health Policy; 2010 Apr; 95(1):1-9. PubMed ID: 19945762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community pharmacist-delivered Medicare Annual Wellness Visits within a family medicine practice.
    Evans TA; Fabel PH; Ziegler B
    J Am Pharm Assoc (2003); 2017; 57(3S):S247-S251. PubMed ID: 28400254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustainable business models: systematic approach toward successful ambulatory care pharmacy practice.
    Sachdev G
    Am J Health Syst Pharm; 2014 Aug; 71(16):1366-74. PubMed ID: 25074956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What Does Provider Status Mean for Pharmacists?
    Consult Pharm; 2015 Aug; 30(8):478-80. PubMed ID: 26260644
    [No Abstract]   [Full Text] [Related]  

  • 32. Current trends in outpatient pharmacy services and billing.
    Beatty SJ; McCormick KM; Beale DJ; Bruggeman AM; Rodis JL; Mehta BH; Bennett MS
    J Am Pharm Assoc (2003); 2012; 52(2):154-60. PubMed ID: 22370377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Billing for cognitive services: understanding Québec pharmacists' behavior.
    Kröger E; Moisan J; Grégoire JP
    Ann Pharmacother; 2000 Mar; 34(3):309-16. PubMed ID: 10917375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of pharmacist charges for medication therapy management services in an outpatient setting.
    Zingone MM; Malcolm KE; McCormick SW; Bledsoe KR
    Am J Health Syst Pharm; 2007 Sep; 64(17):1827-31. PubMed ID: 17724364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes.
    Bero LA; Mays NB; Barjesteh K; Bond C
    Cochrane Database Syst Rev; 2000; (2):CD000336. PubMed ID: 10796529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication therapy management: a challenge for pharmacists.
    Gruber J
    Consult Pharm; 2012 Nov; 27(11):782-96. PubMed ID: 23168928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathway to pharmacist medical provider status in Washington State.
    Hazlet TK; Karwaki TE; Downing DF
    J Am Pharm Assoc (2003); 2017; 57(1):116-119. PubMed ID: 27836482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Go West, young pharmacist.
    Manag Care; 2004 Dec; 13(12):13. PubMed ID: 15696632
    [No Abstract]   [Full Text] [Related]  

  • 39. Medicare part D: good for patients and an opportunity for pharmacists.
    Benner JS; Kocot SL
    J Manag Care Pharm; 2009; 15(1):66-70. PubMed ID: 19125552
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic drug monitoring in ambulatory care.
    Goode MA; Gums JG
    Ann Pharmacother; 1993 Apr; 27(4):502-5. PubMed ID: 8477129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.